Analysts: CVS Caremark Corp (CVS.N)
CVS.N on New York Stock Exchange
61.74USD
10:55am EDT
61.74USD
10:55am EDT
Price Change (% chg)
$-0.43 (-0.69%)
$-0.43 (-0.69%)
Prev Close
$62.17
$62.17
Open
$61.96
$61.96
Day's High
$61.96
$61.96
Day's Low
$61.60
$61.60
Volume
205,832
205,832
Avg. Vol
1,314,507
1,314,507
52-wk High
$62.22
$62.22
52-wk Low
$43.65
$43.65
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.97 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 9 | 10 | 9 | 7 |
| (2) OUTPERFORM | 12 | 12 | 12 | 12 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.70 | 1.67 | 1.70 | 1.76 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 16 | 31,267.50 | 31,875.00 | 30,729.70 | 31,668.30 |
| Quarter Ending Dec-13 | 16 | 32,569.80 | 32,956.00 | 32,017.80 | 32,989.90 |
| Year Ending Dec-13 | 19 | 125,771.00 | 126,658.00 | 124,711.00 | 128,510.00 |
| Year Ending Dec-14 | 19 | 130,925.00 | 135,422.00 | 124,697.00 | 131,681.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 19 | 0.97 | 1.04 | 0.94 | 0.95 |
| Quarter Ending Dec-13 | 19 | 1.22 | 1.26 | 1.19 | 1.17 |
| Year Ending Dec-13 | 20 | 3.98 | 4.10 | 3.92 | 3.71 |
| Year Ending Dec-14 | 21 | 4.45 | 4.65 | 4.20 | 4.24 |
| LT Growth Rate (%) | 4 | 13.82 | 14.30 | 13.00 | 13.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 30,357.60 | 30,763.00 | 405.41 | 1.34 |
| Quarter Ending Dec-12 | 31,128.50 | 31,394.00 | 265.54 | 0.85 |
| Quarter Ending Sep-12 | 30,088.30 | 30,227.00 | 138.73 | 0.46 |
| Quarter Ending Jun-12 | 30,963.40 | 30,714.00 | 249.44 | 0.81 |
| Quarter Ending Mar-12 | 30,306.50 | 30,798.00 | 491.52 | 1.62 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.79 | 0.83 | 0.04 | 4.52 |
| Quarter Ending Dec-12 | 1.10 | 0.97 | 0.13 | 12.01 |
| Quarter Ending Sep-12 | 0.84 | 0.85 | 0.01 | 1.43 |
| Quarter Ending Jun-12 | 0.80 | 0.81 | 0.01 | 1.66 |
| Quarter Ending Mar-12 | 0.63 | 0.65 | 0.02 | 3.16 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 31,267.50 | 31,267.50 | 31,174.60 | 31,174.60 | 31,668.30 |
| Quarter Ending Dec-13 | 32,569.80 | 32,569.80 | 32,561.60 | 32,561.60 | 32,989.90 |
| Year Ending Dec-13 | 125,771.00 | 125,771.00 | 125,769.00 | 125,748.00 | 128,510.00 |
| Year Ending Dec-14 | 130,925.00 | 130,956.00 | 130,801.00 | 130,624.00 | 131,681.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.97 | 0.97 | 0.97 | 0.98 | 0.95 |
| Quarter Ending Dec-13 | 1.22 | 1.22 | 1.22 | 1.22 | 1.17 |
| Quarter Ending Dec-13 | 3.98 | 3.98 | 3.98 | 3.99 | 3.71 |
| Quarter Ending Dec-14 | 4.45 | 4.45 | 4.45 | 4.44 | 4.24 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 0 | 0 | 2 |
| Year Ending Dec-14 | 0 | 1 | 2 | 3 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (CVS). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$495.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates